Natural products for drug discovery in the 21st century: innovations for novel drug discovery

NE Thomford, DA Senthebane, A Rowe… - International journal of …, 2018 - mdpi.com
The therapeutic properties of plants have been recognised since time immemorial. Many
pathological conditions have been treated using plant-derived medicines. These medicines …

Counting on natural products for drug design

T Rodrigues, D Reker, P Schneider, G Schneider - Nature chemistry, 2016 - nature.com
Natural products and their molecular frameworks have a long tradition as valuable starting
points for medicinal chemistry and drug discovery. Recently, there has been a revitalization …

Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area

X Ran, JE Gestwicki - Current opinion in chemical biology, 2018 - Elsevier
Protein–protein interactions (PPI) were once considered 'undruggable', but clinical
successes, driven by advanced methods in drug discovery, have challenged that notion …

[HTML][HTML] The role of natural products as sources of therapeutic agents for innovative drug discovery

K Dzobo - Comprehensive pharmacology, 2022 - ncbi.nlm.nih.gov
Emerging threats to human health require a concerted effort in search of both preventive and
treatment strategies, placing natural products at the center of efforts to obtain new therapies …

[HTML][HTML] Androgen receptor-dependent and-independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

DT Hoang, KA Iczkowski, D Kilari, W See… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Despite aggressive treatment for localized cancer, prostate cancer (PC) remains a leading
cause of cancer-related death for American men due to a subset of patients progressing to …

Direct targeting options for STAT3 and STAT5 in cancer

A Orlova, C Wagner, ED de Araujo, D Bajusz… - Cancers, 2019 - mdpi.com
Signal transducer and activator of transcription (STAT) 3 and STAT5 are important
transcription factors that are able to mediate or even drive cancer progression through …

Discovery of a Potent and Selective STAT5 PROTAC Degrader with Strong Antitumor Activity In Vivo in Acute Myeloid Leukemia

A Kaneshige, L Bai, M Wang… - Journal of medicinal …, 2023 - ACS Publications
STAT5 is an attractive therapeutic target for human cancers. We report herein the discovery
of a potent and selective STAT5 degrader with strong antitumor activity in vivo. We first …

The pharmacophore concept and its applications in computer-aided drug design

T Seidel, DA Schuetz, A Garon, T Langer - Progress in the Chemistry of …, 2019 - Springer
Pharmacophore-based techniques currently are an integral part of many computer-aided
drug design workflows and have been successfully and extensively applied for tasks such …

Pharmacological inhibition of oncogenic STAT3 and STAT5 signaling in hematopoietic cancers

M Brachet-Botineau, M Polomski, HA Neubauer… - Cancers, 2020 - mdpi.com
Signal Transducer and Activator of Transcription (STAT) 3 and 5 are important effectors of
cellular transformation, and aberrant STAT3 and STAT5 signaling have been demonstrated …

STAT5A and STAT5B—twins with different personalities in hematopoiesis and leukemia

B Maurer, S Kollmann, J Pickem, A Hoelbl-Kovacic… - Cancers, 2019 - mdpi.com
The transcription factors STAT5A and STAT5B have essential roles in survival and
proliferation of hematopoietic cells—which have been considered largely redundant …